MetaVia completes dose titration in Phase 1 Part 3 obesity trial
Tweet Send to a Friend
MetaVia Inc. (Nasdaq: MTVA) announced that all active patients enrolled in Part 3 of its Phase 1 clinical trial evaluating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
